Healing of chronic arterial and venous leg ulcers with systemic electromagnetic fields

被引:32
作者
Cañedo-Dorantes, L
García-Cantú, R
Barrera, R
Méndez-Ramírez, I
Navarro, VH
Serrano, G
机构
[1] Hosp Juarez Mexico, Div Invest, SSA, Mexico City 00760, DF, Mexico
[2] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ingn Elect, Mexico City 07000, DF, Mexico
[3] SSA, Inst Enfermedades Resp, Dept Bioquim, Mexico City, DF, Mexico
[4] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Dept Estadist, Mexico City 04510, DF, Mexico
[5] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo XXI, Hosp Especialidades, Serv Angiol, Mexico City 04510, DF, Mexico
关键词
leg ulcers; skin ulcers; electromagnetic fields; cell activation;
D O I
10.1016/S0188-4409(02)00357-0
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Mitogen-activated autologous peripheral blood mononuclear cells applied locally on the ulcer surface promote healing of chronic arterial and venous leg ulcers. In vitro, extremely low frequency electromagnetic fields (ELF) interact with peripheral C, blood mononuclear cells (PBMC) via Ca++ channels, activating signal transduction cascades, promoting cytokine synthesis, and changing cell proliferation patterns. Methods. ELF frequencies were configured to interact in vitro with the proliferation patterns of PBMC obtained from normal human volunteers. These ELF were then applied peripherally as the sole treatment to 26 patients with 42 chronic leg ulcers of predominantly arterial or venous etiology unresponsive to previous medical and/or surgical treatments in a phase I before-after design. Results. At admission, age of ulcers had a skewed distribution with a median of 639 days. Wound healing or deleterious effects began in all patients during the first 2 weeks after ELF exposure, permitting their previously unresponsive ulcers to function as internal controls. After ELF exposure, 69% of all lesions were cured or healed >50% in a period <4 months. Defective wound healing was observed in lesions associated with important arterial occlusion, uncontrolled arterial hypertension, severe lipodermatosclerosis, non-pitting edema, and obesity (body mass index >30). Lesions worsened in patients with autoimmune diseases. Conclusions. Systemic effects are hypothetically explained by ELF activation of PBMC and their subsequent transportation to the ulcer site via humoral route. This therapy is effective in selected patients with chronic arterial and venous leg ulcers. (C) 2002 IMSS. Published by Elsevier Science Inc.
引用
收藏
页码:281 / 289
页数:9
相关论文
共 40 条
[1]  
[Anonymous], 2014, SCI TRANSL MED, DOI DOI 10.1126/scitranslmed.3009337
[2]   Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [J].
Baumgartner, I ;
Pieczek, A ;
Manor, O ;
Blair, R ;
Kearney, M ;
Walsh, K ;
Isner, JM .
CIRCULATION, 1998, 97 (12) :1114-1123
[3]   Microvascular changes in venous disease: An update [J].
Bollinger, A ;
Leu, AJ ;
Hoffmann, U ;
Franzeck, UK .
ANGIOLOGY, 1997, 48 (01) :27-32
[4]  
BROWSE NL, 1982, LANCET, V2, P243
[5]  
CADOSSI R, 1994, NATURE ELECTROMAGNET, P157
[6]   Pyoderma gangrenosum [J].
Callen, JP .
LANCET, 1998, 351 (9102) :581-585
[7]  
Cheatle T R, 1991, Eur J Vasc Surg, V5, P115, DOI 10.1016/S0950-821X(05)80674-7
[8]   EXTREMELY LOW-FREQUENCY PULSED ELECTROMAGNETIC-FIELDS INCREASE INTERLEUKIN-2 (IL-2) UTILIZATION AND IL-2 RECEPTOR EXPRESSION IN MITOGEN-STIMULATED HUMAN-LYMPHOCYTES FROM OLD SUBJECTS [J].
COSSARIZZA, A ;
MONTI, D ;
BERSANI, F ;
PAGANELLI, R ;
MONTAGNANI, G ;
CADOSSI, R ;
CANTINI, M ;
FRANCESCHI, C .
FEBS LETTERS, 1989, 248 (1-2) :141-144
[9]   EXTREMELY LOW-FREQUENCY PULSED ELECTROMAGNETIC-FIELDS INCREASE CELL-PROLIFERATION IN LYMPHOCYTES FROM YOUNG AND AGED SUBJECTS [J].
COSSARIZZA, A ;
MONTI, D ;
BERSANI, F ;
CANTINI, M ;
CADOSSI, R ;
SACCHI, A ;
FRANCESCHI, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (02) :692-698
[10]   EXPOSURE TO LOW-FREQUENCY PULSED ELECTROMAGNETIC-FIELDS INCREASES INTERLEUKIN-1 AND INTERLEUKIN-6 PRODUCTION BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS [J].
COSSARIZZA, A ;
ANGIONI, S ;
PETRAGLIA, F ;
GENAZZANI, AR ;
MONTI, D ;
CAPRI, M ;
BERSANI, F ;
CADOSSI, R ;
FRANCESCHI, C .
EXPERIMENTAL CELL RESEARCH, 1993, 204 (02) :385-387